RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Rallybio Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$16.35+0.07 (+0.43%)
Close on Oct 19, 2026
- Market cap
- $94.80M
- P/E (TTM)
- 2.1
- Dividend yield
- –
Community
Notes and questions about Rallybio from other investors
No posts about RLYB yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.